Literature DB >> 2432152

Structural analysis of human Ia antigens reveals the existence of a fourth molecular subset distinct from DP, DQ, and DR molecules.

G Carra, R S Accolla.   

Abstract

Structural analysis by two-dimensional peptide maps (2D-PM) of the human Ia molecular pool expressed on the cell surface of two distinct lymphoblastoid cell line, LG-2 and Raji, revealed the existence of a novel MHC class II molecular heterodimer that differs at the level of both alpha and beta subunits from the previously described DP, DQ, and DR antigens. These differences were also seen at the level of two-dimensional electrophoresis (2D-PAGE) of biosynthetically labeled intact molecules, although to a lesser extent, due to the intrinsic limitations of this technique in resolving fine structural differences. We have designated this new class II antigen as the fourth Ia subset. The fourth Ia subset seems to represent a small proportion of the human Ia pool. Comparative analysis by 2D-PM of the two cell lines showed the presence of structural variations in the alpha chains of the fourth Ia subset, suggesting the existence of polymorphism for these subunits. Cell surface iodination did not show appreciable labeling of the fourth subset beta chain in LG-2 cells, and this prevented analysis of the structural polymorphism of this subunit. Furthermore, for the first time, we have shown that DP alpha chains display distinct peptide maps in LG-2 and Raji cells, thus suggesting the presence of structural polymorphism for these Ia subunits also. The DQ1 alpha and beta allelic products present in LG-2 cells (DQ homozygous) did not show appreciable structural variation when compared with the homologous allelic products present in Raji cells (DQ heterozygous). Finally, we have confirmed the absence of polymorphism for the DR alpha subunits. By 2D-PM, relatively low structural variation was instead found for the highly polymorphic DR beta subunits expressed in the two cell lines, suggesting that cell surface iodination preferentially labels constant domains of DR beta chains.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2432152      PMCID: PMC2188257          DOI: 10.1084/jem.165.1.47

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Biosynthesis and maturation of HLA-DR antigens in vivo.

Authors:  M J Owen; A M Kissonerghis; H F Lodish; M J Crumpton
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

2.  Distinct forms of both alpha and beta subunits are present in the human Ia molecular pool.

Authors:  R S Accolla; N Gross; S Carrel; G Corte
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

3.  Isotypic and allotypic variation of human class II histocompatibility antigen alpha-chain genes.

Authors:  C Auffray; J W Lillie; D Arnot; D Grossberger; D Kappes; J L Strominger
Journal:  Nature       Date:  1984 Mar 22-28       Impact factor: 49.962

4.  Biochemical characterization of an invariant polypeptide associated with Ia antigens in human and mouse.

Authors:  D J Charron; M F Aellen-Schulz; J St Geme; H A Erlich; H O McDevitt
Journal:  Mol Immunol       Date:  1983-01       Impact factor: 4.407

5.  Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.

Authors:  D A Shackelford; D L Mann; J J van Rood; G B Ferrara; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

6.  Detection of a novel human class II HLA antigen.

Authors:  A J Watson; R DeMars; I S Trowbridge; F H Bach
Journal:  Nature       Date:  1983 Jul 28-Aug 3       Impact factor: 49.962

7.  Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets.

Authors:  R S Accolla
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

8.  Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains.

Authors:  L Schenning; D Larhammar; P Bill; K Wiman; A K Jonsson; L Rask; P A Peterson
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

9.  Immunological dissection of human Ia molecules.

Authors:  R Tosi; N Tanigaki; D Centis; G B Ferrara; D Pressman
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

10.  Analysis of the structural heterogeneity and polymorphism of human Ia antigens. Four distinct subsets of molecules are coexpressed in the Ia pool of both DR1,1 homozygous and DR3,W6 heterozygous B cell lines.

Authors:  R S Accolla
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

View more
  7 in total

1.  The HLA-DNA (DZA) gene is correctly expressed as a 1.1 kb mature mRNA transcript.

Authors:  J A Young; J Trowsdale
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 2.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

Review 3.  Lymphoepithelial interactions in the mucosal immune system.

Authors:  P Brandtzaeg; L M Sollid; P S Thrane; D Kvale; K Bjerke; H Scott; K Kett; T O Rognum
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

4.  A novel HLA class II molecule.

Authors:  N Fernandez; M O Labeta; H Festenstein
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

5.  Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells.

Authors:  F Latron; M Jotterand-Bellomo; A Maffei; L Scarpellino; M Bernard; J L Strominger; R S Accolla
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  DY determinants, possibly associated with novel class II molecules, stimulate autoreactive CD4+ T cells with suppressive activity.

Authors:  G Pawelec; N Fernandez; T Brocker; E M Schneider; H Festenstein; P Wernet
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

7.  A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gamma.

Authors:  C A Siegrist; E Martinez-Soria; I Kern; B Mach
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.